Issue 3, 2014

Heteroleptic titanium(iv) catecholato/piperazine systems and their anti-cancer properties

Abstract

In this paper we report the synthesis and full characterisation of a range of Ti(IV)-catecholato systems complexed to piperazine or homopiperazine salan ligands. The steric/electronic environment of the catecholate moiety has been varied and the effect this has on cytotoxicity discussed. It was observed that the 7-membered homopiperazine complexes are more stable to hydrolysis than their piperazine cousins in biological media. In general the homopiperazine complexes show higher cytotoxicity than the piperazine complexes, with the most cytotoxic complex exhibiting IC50 (μM) values of 3 ± 0.5 μM (HT-29) and 4 ± 1 μM (OVCAR).

Graphical abstract: Heteroleptic titanium(iv) catecholato/piperazine systems and their anti-cancer properties

Supplementary files

Article information

Article type
Paper
Submitted
18 Sep 2013
Accepted
30 Oct 2013
First published
30 Oct 2013

Dalton Trans., 2014,43, 1380-1385

Heteroleptic titanium(IV) catecholato/piperazine systems and their anti-cancer properties

S. L. Hancock, R. Gati, M. F. Mahon, E. Y. Tshuva and M. D. Jones, Dalton Trans., 2014, 43, 1380 DOI: 10.1039/C3DT52583J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements